CNBC's Paulina Likos and Zev Fima discuss which Investing Club stocks could come out on top as investors scrutinize AI ...

With 2026 a bit more than half over, Berkshire Hathaway's B shares are down 1.8% year-to-date and 12.4 percentage points ...

The largest housing bill in decades has just become law after weeks of tense political standoff between President Trump and ...

The two companies entered into a high-profile partnership in 2024 when ChatGPT was integrated into the iPhone's operating ...

"Funflation," the rising cost of concerts, sporting events and travel, is surging across America. But alternatives at home, ...

CNBC’s MacKenzie Sigalos reports on Apple’s claims that OpenAI employees and recruits took confidential documents, physical ...

Some states may have low costs and light regulation, but high crime and lack of healthcare are among important factors when ...

CNBC's Paulina Likos and Zev Fima discuss Wall Street's shift from AI euphoria toward rationalization and what it means for investors.

Vivani Medical is developing an implant of semaglutide, the active ingredient in Novo Nordisk's obesity injection Wegovy and ...

CNBC's Pippa Stevens reports on how disrupted traffic through the Strait of Hormuz and Ukraine increasing attacks on Russian ...

CNBC's MacKenzie Sigalos abd Kristina Partsinevelos recap Apple filing legal action against OpenAI. Got a confidential news ...

The Financial Select Sector Index trades at roughly 15.5 times forward earnings — about a turn and a quarter cheaper than ...